Bladder EpiCheck
Urine DNA methylation test for non-invasive monitoring of bladder cancer recurrence; jurisdiction-specific indications remain separate.
- Developer
- Nucleix
- Intended use
- Recurrence Detection
- Cancer scope
- Bladder cancer
- Specimen
- Urine
- Molecular modality
- DNA methylation
- Current version
- Current Bladder EpiCheck configuration (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 2 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.